Hypersensitivity drug reaction

A hypersensitivity drug reaction is an immunologically mediated or non-allergic hypersensitivity response triggered by exposure to a pharmaceutical agent, representing an unpredictable, Type B adverse drug reaction Clinically categorized into immediate and delayed phenotypes, these reactions involve varied mechanisms spanning Gell and Coombs Types I through IV, including IgE-mediated mast cell degranulation, cytotoxic antibodies, immune complex deposition, and drug-specific T-cell activation Pat...

A hypersensitivity drug reaction is an immunologically mediated or non-allergic hypersensitivity response triggered by exposure to a pharmaceutical agent, representing an unpredictable, Type B adverse drug reaction

Clinically categorized into immediate and delayed phenotypes, these reactions involve varied mechanisms spanning Gell and Coombs Types I through IV, including IgE-mediated mast cell degranulation, cytotoxic antibodies, immune complex deposition, and drug-specific T-cell activation Clinical manifestations range from mild cutaneous eruptions, such as urticaria and morbilliform exanthems, to severe, multi-organ, or life-threatening systemic syndromes including anaphylaxis, drug reaction with eosino...

Clinically categorized into immediate and delayed phenotypes, these reactions involve varied mechanisms spanning Gell and Coombs Types I through IV, including IgE-mediated mast cell degranulation, cytotoxic antibodies, immune complex deposition, and drug-specific T-cell activation Clinical manifestations range from mild cutaneous eruptions, such as urticaria and morbilliform exanthems, to severe, multi-organ, or life-threatening systemic syndromes including anaphylaxis, drug reaction with eosino...

Clinically categorized into immediate and delayed phenotypes, these reactions involve varied mechanisms spanning Gell and Coombs Types I through IV, including IgE-mediated mast cell degranulation, cytotoxic antibodies, immune complex deposition, and drug-specific T-cell activation

Clinical manifestations range from mild cutaneous eruptions, such as urticaria and morbilliform exanthems, to severe, multi-organ, or life-threatening systemic syndromes including anaphylaxis, drug reaction with eosinophilia and systemic symptoms (DRESS), and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)